CPRX Volume dodolan mangsa ngarep perusahaan catalystpharma.com
Catalyst Pharmaceuticals relies on digital supply logistics and a monopoly in the treatment of Lambert-Eaton myasthenic syndrome. The firm's future sales trend demonstrates long-term capital potential, with 0.76 serving as the current value of the indicator. Business resilience is based on Firdaps patents and regulatory approvals, which determine the company's market success in neuropharmaceuticals.
Rincian metrik keuangan lan pasar Catalyst Pharma (CPRX)
- nilai saham lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Catalyst Pharmaceuticals|CPRX - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Catalyst Pharmaceuticals Inc|CPRX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Catalyst Pharma|CPRX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Catalyst Pharmaceuticals|Rasio cepet catalystpharma.com
- rincian asil keuangan lan kelipatan valuasi:
CPRX - Bathi resik|Proyeksi bathi mangsa ngarep Catalyst Pharmaceuticals|CPRX - Koefisien rega marang bathi|Pangali Forward P/E Catalyst Pharmaceuticals, Inc.|CPRX - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Catalyst Pharma|CPRX - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Catalyst Pharmaceuticals|CPRX - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan catalystpharma.com|CPRX - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Catalyst Pharmaceuticals
- informasi babagan volume dodolan lan pendapatan:
Analisis komprehensif perusahaan:CPRX Catalyst Pharmaceuticals
For Catalyst Pharmaceuticals (CPRX), which has outsourced production and testing to third-party contractors (CRO/CMO), this indicator allows for an assessment of this model's efficiency through the lens of future cash flows. The mathematical revenue projection, reflected in the firm's estimated sales volume, separates market noise from systemic trends, helping investors identify the point of fundamental undervaluation for long-term investment.
Pesaing langsung
Prakiraan pendapatan perusahaan Biogen Inc. (BIIB)|Dodolan mangsa ngarep perusahaan neurocrine.com|Regencell Bioscience Holdings Limited - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan AXSM (Axsome)|ACAD: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan XENE (Xenon Corp)|Viking Therapeutics (VKTX) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan SUPN (supernus.com)|DNLI (Denali Therapeutics Inc.) - Prakiraan volume dodolan|HRMY: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan BHVN|Prakiraan volume dodolan Amylyx Corp (AMLX)|Prakiraan pendapatan perusahaan Trevi Therapeutics TRVI|Pendapatan mangsa ngarep perusahaan PRAX|AVXL - Prakiraan pendapatan perusahaan|CeriBell Inc (CBLL) - Volume dodolan mangsa ngarep perusahaan|PRTA: Prakiraan volume dodolan|Alector (ALEC) - Prakiraan volume dodolan|ANNX (Annexon, Inc.) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Omeros Corp. (OMER)|Prakiraan volume dodolan NGNE|ACIU - Volume dodolan sing dikarepake perusahaan|Voyager Pharma - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Neumora Corp NMRA|SCLX: Volume dodolan mangsa ngarep perusahaan|tevogen.com - Prakiraan volume pendapatan perusahaan|ACOG: Prakiraan volume dodolan|CGTX - Dodolan mangsa ngarep perusahaan|IKT (Inhibikase) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cassava Pharma (SAVA)|Prakiraan volume dodolan ASRT|Prakiraan volume dodolan coyatherapeutics.com (COYA)|Prakiraan pendapatan perusahaan Vistagen VTGN|Ovid Therapeutics Inc - Prakiraan pendapatan perusahaan|ABOS - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan CervoMed Corporation CRVO|ATHE: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Clene|Prakiraan pendapatan perusahaan PepGen Inc|jupiterneurosciences.com - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Relmada (RLMD)|ANVS (Annovis Bio Corporation) - Pendapatan mangsa ngarep perusahaan|Grace Therapeutics - Volume dodolan mangsa ngarep perusahaan|AIFF: Prakiraan pendapatan perusahaan|KLTO - Prakiraan pendapatan perusahaan|NRSN (NeuroSense Therapeutics) - Prakiraan pendapatan perusahaan|RVPH: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan MetaVia (MTVA)|Volume dodolan mangsa ngarep perusahaan NRXS|Prakiraan volume dodolan Helius Medical Technologies Inc.|Prakiraan pendapatan perusahaan Passage Bio, Inc. (PASG)|NEUP (bionomics.com.au) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences Corp NERV|Athira Pharma Corp (ATHA) - Volume dodolan sing dikarepake perusahaan|Addex Therapeutics - Prakiraan volume dodolan|Alzamend Neuro, Inc. (ALZN) - Volume dodolan mangsa ngarep perusahaan|CYCN: Prakiraan volume dodolan|Protagenic Therapeutics, Inc. (PTIX) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan KTTA|CRGT (Cortigent Medical) - Prakiraan volume pendapatan perusahaan|Prakiraan volume dodolan ATXI|Prakiraan volume dodolan brainstorm-cell.com (BCLI)|Prakiraan pendapatan perusahaan Cara Therapeutics CARA|Chromocell Therapeutics Corp - Prakiraan pendapatan perusahaan|ELYM: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Intra-Cellular Therapies|Longboard Pharmaceuticals (LBPH) - Prakiraan pendapatan perusahaan|MRNS - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NRBO (NeuroBo Pharmaceuticals Inc) - Prakiraan volume pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan SAGE (Sage Therapeutics, Inc)|SNPX (Synaptogenix, Inc) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Trevena, Inc. TRVN|VIGL (Vigil Neuroscience Inc.) - Pendapatan sing dikarepake perusahaan|Anew Medical, Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan CERE (Cerevel Therapeutics Inc)
